https://www.macrotrends.net/stocks/charts/XNCR/xencor/financial-statements
Ten years of annual and quarterly financial statements and annual report data for Xencor (XNCR). Income statements, balance sheets, cash flow statements and...
financial statementsxencormacrotrends
https://www.prnewswire.com/news-releases/xencor-to-present-at-30th-annual-piper-jaffray-healthcare-conference-300752468.html
/PRNewswire/ -- Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of...
piper jaffrayhealthcare conferencexencorpresentannual
https://www.businesswire.com/news/home/20260108654667/en/Xencor-Highlights-Corporate-Priorities-and-2026-Pipeline-Milestones
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, ...
corporate prioritiesxencorhighlightspipelinemilestones
https://www.pharmaceutical-technology.com/data-insights/xencor-gets-grant-for-bispecific-antibody-for-treating-gpc3-associated-cancers/
Discover Xencor Inc's groundbreaking patent for novel GPC3 binding domains and bispecific antibodies targeting GPC3-associated cancers. Explore the innovative...
bispecific antibodyxencorincfilespatent
https://www.businesswire.com/news/home/20250313419179/en/Xencor-Appoints-Todd-Simpson-to-Board-of-Directors
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, ...
todd simpsonxencorappointsboarddirectors
https://www.ig.com/ch/aktien/maerkte-aktien/xencor-inc
Xencor, Inc. is a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases.... [CH]
aktien handelnxencorincrealtimeaktienkurs